...Biocartis spun out newco MyCartis (Lausanne, Switzerland), a combination of Pronota and Biocartis' Evalution unit, which... ...and nucleic acid-based biomarker analysis. The technology was previously known as Dynamic Multi-Analyte Technology (DMAT). Pronota... ...patients. Idylla (formerly Apollo) is an automated molecular diagnostic system. Biocartis S.A. , Lausanne, Switzerland Pronota N.V....
...investors also participated (see BioCentury, Nov. 18, 2013) . Newco MyCartis is a combination of Pronota N.V.... ...and nucleic acid-based biomarker analysis. The technology was previously known as Dynamic Multi-Analyte Technology (DMAT). Pronota...
...Detection (IMPROvED) consortium to develop a predictive preeclampsia diagnostic. The project, which includes Metabolomic and Pronota... ...time. The partners could not be reached for details. Metabolomic Diagnostics Ltd. , Cork, Ireland Pronota N.V....
...A validation study in 300 women showed that Pronota's mid-gestation preeclampsia screening test correctly identified 80%... ...information from 5,600 women in Australia, New Zealand, the U.K. and Ireland over 8 years. Pronota N.V....
Pronota N.V. , Zwijnaarde, Belgium Business: Diagnostic, Pharmacogenetics Hired: Carol Greve-Philips as CBO, formerly VP of corporate development at Genzyme Corp. , which Sanofi acquired; and Els Hubloux as CFO, formerly senior investment manager at Capricorn Venture...
...Chemical Holdings' Molecuence Corp. subsidiary partnered to discover and validate protein biomarkers to diagnose stroke. Pronota... ...protein biomarker discovery platform and MASSterclass protein biomarker verification tool. Further terms were not disclosed. Pronota N.V....
...Biocartis spun out newco MyCartis (Lausanne, Switzerland), a combination of Pronota and Biocartis' Evalution unit, which... ...and nucleic acid-based biomarker analysis. The technology was previously known as Dynamic Multi-Analyte Technology (DMAT). Pronota... ...patients. Idylla (formerly Apollo) is an automated molecular diagnostic system. Biocartis S.A. , Lausanne, Switzerland Pronota N.V....
...investors also participated (see BioCentury, Nov. 18, 2013) . Newco MyCartis is a combination of Pronota N.V.... ...and nucleic acid-based biomarker analysis. The technology was previously known as Dynamic Multi-Analyte Technology (DMAT). Pronota...
...Detection (IMPROvED) consortium to develop a predictive preeclampsia diagnostic. The project, which includes Metabolomic and Pronota... ...time. The partners could not be reached for details. Metabolomic Diagnostics Ltd. , Cork, Ireland Pronota N.V....
...A validation study in 300 women showed that Pronota's mid-gestation preeclampsia screening test correctly identified 80%... ...information from 5,600 women in Australia, New Zealand, the U.K. and Ireland over 8 years. Pronota N.V....
Pronota N.V. , Zwijnaarde, Belgium Business: Diagnostic, Pharmacogenetics Hired: Carol Greve-Philips as CBO, formerly VP of corporate development at Genzyme Corp. , which Sanofi acquired; and Els Hubloux as CFO, formerly senior investment manager at Capricorn Venture...
...Chemical Holdings' Molecuence Corp. subsidiary partnered to discover and validate protein biomarkers to diagnose stroke. Pronota... ...protein biomarker discovery platform and MASSterclass protein biomarker verification tool. Further terms were not disclosed. Pronota N.V....